Nasdaq
Published November 16, 2026 · Updated November 17, 2026
Clearmind Achieves Full Enrollment for Part C in CMND-100 Phase I/IIa Trial, Marking Key ...
Clearmind Medicine Inc., a clinical-stage biopharmaceutical company advancing non- hallucinogenic psychedelic ... press release . Clearmind is not.
Surfaced by this Google Alert
- Psychedelic press release